Meihua International Medical Technologies Co., Ltd. (MHUA) 10-Year Financial Performance & Capital Metrics

MHUA • • Industrial / General

HealthcareMedical InstrumentsMedical Consumables & DisposablesMedical Packaging & Containers

AboutMeihua International Medical Technologies Co., Ltd. engages in the manufacture and marketing of medical consumables in the People's Republic of China. It offers class I, II, and III disposable medical devices. The company's products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles. It also distributes disposable medical devices sourced from other manufacturers to customers in China. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.Show more

Revenue $97M -0.2%
EBITDA $15M -1.7%
Net Income $11M -6.7%
EPS (Diluted) 40.00 -18.4%
Gross Margin 34.36% +0.8%
EBITDA Margin 15.36% -1.5%
Operating Margin 14.77% -2.3%
Net Margin 11.19% -6.5%
ROE 7.09% -12.9%
ROIC 7.45% -13.4%
Debt/Equity 0.05 +0.1%
Interest Coverage 9.50 -83.8%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓High quality earnings: Operating CF exceeds net income
✓Healthy 5Y average net margin of 14.1%
✓Trading at only 0.0x book value

✗Weaknesses

✗Weak momentum: RS Rating 0 (bottom 0%)
✗Shares diluted 14.3% in last year
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y4.01%

3Y-2.34%

TTM-11.3%

Profit (Net Income) CAGR

10Y-

5Y-6.81%

3Y-19.71%

TTM-26.27%

EPS CAGR

10Y-

5Y-8.97%

3Y-23.4%

TTM-44.54%

ROCE

10Y Avg24.07%

5Y Avg17.63%

3Y Avg9.45%

Latest9.36%

Peer Comparison

Medical Packaging & Containers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
STVNStevanato Group S.p.A.	1.04B	21.00	48.84	1.72%	12.01%	9.78%		0.31
WSTWest Pharmaceutical Services, Inc.	20.1B	279.41	41.77	-1.98%	16.3%	16.11%	1.38%	0.11
ATRAptarGroup, Inc.	8.21B	125.11	22.62	2.74%	11.45%	14.91%	4.25%	0.43
MHUAMeihua International Medical Technologies Co., Ltd.	181.69M	3.25	0.08	-0.19%	10.09%	11.25%	7.98%	0.05

Profit & Loss

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	75.71M	79.63M	89.06M	104.04M	103.35M	97.1M	96.91M
Revenue Growth %	-	0.05%	0.12%	0.17%	-0.01%	-0.06%	-0%
Cost of Goods Sold+	43.82M	47.42M	51.9M	64.23M	65.25M	64M	63.61M
COGS % of Revenue	0.58%	0.6%	0.58%	0.62%	0.63%	0.66%	0.66%
Gross Profit+	31.89M	32.21M	37.16M	39.81M	38.1M	33.09M	33.3M
Gross Margin %	0.42%	0.4%	0.42%	0.38%	0.37%	0.34%	0.34%
Gross Profit Growth %	-	0.01%	0.15%	0.07%	-0.04%	-0.13%	0.01%
Operating Expenses+	13.1M	12.82M	13.69M	14.5M	22.54M	18.42M	18.99M
OpEx % of Revenue	0.17%	0.16%	0.15%	0.14%	0.22%	0.19%	0.2%
Selling, General & Admin	9.85M	8.68M	10.34M	11.78M	18.68M	12.97M	13.52M
SG&A % of Revenue	0.13%	0.11%	0.12%	0.11%	0.18%	0.13%	0.14%
Research & Development	2.87M	3.21M	2.49M	2.73M	2.96M	2.75M	3.46M
R&D % of Revenue	0.04%	0.04%	0.03%	0.03%	0.03%	0.03%	0.04%
Other Operating Expenses	0	926.2K	864.79K	0	898.66K	2.7M	2.01M
Operating Income+	19.18M	19.39M	23.47M	26.26M	10.8M	14.67M	14.31M
Operating Margin %	0.25%	0.24%	0.26%	0.25%	0.1%	0.15%	0.15%
Operating Income Growth %	-	0.01%	0.21%	0.12%	-0.59%	0.36%	-0.02%
EBITDA+	19.74M	19.9M	23.99M	26.88M	11.37M	15.15M	14.88M
EBITDA Margin %	0.26%	0.25%	0.27%	0.26%	0.11%	0.16%	0.15%
EBITDA Growth %	-	0.01%	0.21%	0.12%	-0.58%	0.33%	-0.02%
D&A (Non-Cash Add-back)	567.77K	509.22K	523.43K	622.47K	563.46K	470.99K	571.03K
EBIT	19.18M	19.35M	23.87M	26.41M	11.09M	15.3M	15.13M
Net Interest Income+	0	-48.95K	-100.58K	-156.89K	-130.94K	622.66K	-492.3K
Interest Income	77.42K	48.84K	36.58K	23.86K	63.73K	873.44K	1.01M
Interest Expense	0	97.79K	137.16K	180.74K	194.67K	250.78K	1.51M
Other Income/Expense	-465.98K	-137.69K	267.35K	-32.91K	89.28K	373.84K	-685.78K
Pretax Income+	18.71M	19.25M	23.73M	26.23M	10.89M	15.05M	13.63M
Pretax Margin %	0.25%	0.24%	0.27%	0.25%	0.11%	0.15%	0.14%
Income Tax+	3.23M	3.82M	4.69M	5.28M	4.71M	3.46M	2.79M
Effective Tax Rate %	0.83%	0.8%	0.8%	0.8%	0.57%	0.77%	0.8%
Net Income+	15.48M	15.43M	19.05M	20.95M	6.24M	11.63M	10.84M
Net Margin %	0.2%	0.19%	0.21%	0.2%	0.06%	0.12%	0.11%
Net Income Growth %	-	-0%	0.23%	0.1%	-0.7%	0.86%	-0.07%
Net Income (Continuing)	15.48M	15.43M	19.05M	20.95M	6.18M	11.59M	10.84M
Discontinued Operations	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	556.14K	505.98K	0
EPS (Diluted)+	77.00	64.00	79.00	89.00	27.00	49.00	40.00
EPS Growth %	-	-0.17%	0.23%	0.13%	-0.7%	0.81%	-0.18%
EPS (Basic)	77.00	64.00	79.00	89.00	27.00	49.00	40.00
Diluted Shares Outstanding	200K	241.4K	241.4K	236K	234.11K	239.4K	273.72K
Basic Shares Outstanding	200K	241.4K	241.4K	236K	234.11K	239.4K	273.72K
Dividend Payout Ratio	-	-	-	-	-	-	-

Balance Sheet

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	49.97M	52.58M	67.57M	97.28M	135.32M	132.24M	143.44M
Cash & Short-Term Investments	14.8M	16.03M	7.19M	8.15M	26.74M	16.93M	15.96M
Cash Only	14.8M	16.03M	7.19M	8.15M	26.74M	16.93M	15.96M
Short-Term Investments	0	0	0	0	0	0	0
Accounts Receivable	32.98M	35.41M	58.56M	86.48M	91.03M	99.48M	115M
Days Sales Outstanding	159	162.33	239.98	303.41	321.51	373.95	433.13
Inventory	1.84M	1.02M	1.33M	1.25M	1.12M	1.62M	1.41M
Days Inventory Outstanding	15.36	7.89	9.33	7.11	6.28	9.22	8.09
Other Current Assets	344.84K	107.94K	496.61K	1.39M	16.43M	14.23M	1.48M
Total Non-Current Assets+	12.45M	20.63M	38.48M	39.58M	28.26M	39.68M	42.8M
Property, Plant & Equipment	3.7M	3.4M	20.13M	7.48M	8.76M	8.84M	7.89M
Fixed Asset Turnover	20.46x	23.41x	4.42x	13.91x	11.80x	10.99x	12.29x
Goodwill	0	0	0	-17.26M	0	0	0
Intangible Assets	600.78K	16.37M	17.43M	17.82M	497.6K	3.92M	443.04K
Long-Term Investments	872.66K	861.85K	919.54K	941.53K	6.67M	6.13M	22.39M
Other Non-Current Assets	7.27M	15.8M	29.89M	30.6M	12.33M	20.42M	11.09M
Total Assets+	62.42M	73.2M	106.05M	136.86M	163.58M	171.92M	186.24M
Asset Turnover	1.21x	1.09x	0.84x	0.76x	0.63x	0.56x	0.52x
Asset Growth %	-	0.17%	0.45%	0.29%	0.2%	0.05%	0.08%
Total Current Liabilities+	17.96M	13.55M	21.31M	29.09M	24.17M	25.07M	27.26M
Accounts Payable	13.73M	9.36M	15.64M	20.98M	16.1M	15.82M	15.48M
Days Payables Outstanding	114.33	72.05	109.98	119.22	90.04	90.23	88.8
Short-Term Debt	2.04M	2.59M	3.22M	5.18M	6.09M	7.32M	7.95M
Deferred Revenue (Current)	0	0	1000K	0	0	0	0
Other Current Liabilities	956.04K	851.17K	-494.98K	0	0	409.89K	1.33M
Current Ratio	2.78x	3.88x	3.17x	3.34x	5.60x	5.27x	5.26x
Quick Ratio	2.68x	3.81x	3.11x	3.30x	5.55x	5.21x	5.21x
Cash Conversion Cycle	60.03	98.17	139.33	191.29	237.74	292.95	352.42
Total Non-Current Liabilities+	0	0	0	0	724.93K	4.59K	0
Long-Term Debt	0	0	0	0	724.93K	0	0
Capital Lease Obligations	0	0	0	0	0	4.59K	0
Deferred Tax Liabilities	0	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	0	0	0	0
Total Liabilities	17.96M	13.55M	21.31M	30.05M	24.9M	25.08M	27.26M
Total Debt+	2.04M	2.59M	3.22M	5.18M	6.81M	7.33M	7.95M
Net Debt	-12.77M	-13.45M	-3.97M	-2.97M	-19.92M	-9.6M	-8.01M
Debt / Equity	0.05x	0.04x	0.04x	0.05x	0.05x	0.05x	0.05x
Debt / EBITDA	0.10x	0.13x	0.13x	0.19x	0.60x	0.48x	0.53x
Net Debt / EBITDA	-0.65x	-0.68x	-0.17x	-0.11x	-1.75x	-0.63x	-0.54x
Interest Coverage	-	198.26x	171.09x	145.29x	55.49x	58.52x	9.50x
Total Equity+	44.46M	59.66M	84.74M	106.81M	138.68M	146.84M	158.98M
Equity Growth %	-	0.34%	0.42%	0.26%	0.3%	0.06%	0.08%
Book Value per Share	222.31	247.13	351.02	452.59	592.36	613.36	580.80
Total Shareholders' Equity	44.46M	59.66M	84.74M	106.81M	138.12M	146.33M	158.98M
Common Stock	10K	10K	10K	10K	11.97K	11.97K	15.95K
Retained Earnings	37.33M	52.76M	56.63M	76.62M	83.33M	94.64M	105.23M
Treasury Stock	0	0	0	0	0	0	-200K
Accumulated OCI	-2.59M	-2.83M	18.38M	20.47M	11.81M	8.72M	4.71M
Minority Interest	0	0	0	0	556.14K	505.98K	0

Cash Flow

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	11.82M	9.31M	5.33M	-54.66K	-9.16M	2.28M	14.64M
Operating CF Margin %	0.16%	0.12%	0.06%	-0%	-0.09%	0.02%	0.15%
Operating CF Growth %	-	-0.21%	-0.43%	-1.01%	-166.63%	1.25%	5.43%
Net Income	15.48M	15.43M	19.05M	19.99M	6.18M	11.59M	10.84M
Depreciation & Amortization	567.77K	509.22K	523.43K	622.47K	563.46K	470.99K	571.03K
Stock-Based Compensation	0	0	0	0	0	0	0
Deferred Taxes	0	0	0	0	0	-370.48K	-642.63K
Other Non-Cash Items	6.71M	-9.53K	2.85K	15.28K	4.51M	2.18M	3.9M
Working Capital Changes	-10.94M	-6.62M	-14.25M	-20.68M	-20.41M	-11.6M	-27.97K
Change in Receivables	-11.09M	-4.71M	-13.64M	-20.07M	-7.12M	-14.02M	-3.21M
Change in Inventory	-170.6K	802.61K	-219.79K	105.12K	35.03K	-528.63K	165.76K
Change in Payables	0	-4.23M	5.34M	4.91M	-3.37M	185.9K	932.49K
Cash from Investing+	-7.57M	-8.9M	-16.09M	-833.82K	-8.62M	-12.46M	-20.42M
Capital Expenditures	-12.3K	-8.95M	-16.12M	-850.23K	-2.7M	-1.18M	-133.55K
CapEx % of Revenue	0%	0.11%	0.18%	0.01%	0.03%	0.01%	0%
Acquisitions	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-
Other Investing	-7.56M	0	0	0	23.15K	-11.63M	-15.9M
Cash from Financing+	-4.2M	923.77K	1.71M	1.86M	37.25M	706.13K	6.21M
Debt Issued (Net)	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-
Other Financing	-4.2M	344.74K	0	0	635.31K	0	0
Net Change in Cash	-	-	-	-	-	-	-
Free Cash Flow+	11.8M	356.12K	-10.79M	-904.89K	-11.86M	-2.41M	14.5M
FCF Margin %	0.16%	0%	-0.12%	-0.01%	-0.11%	-0.02%	0.15%
FCF Growth %	-	-0.97%	-31.31%	0.92%	-12.11%	0.8%	7.02%
FCF per Share	59.02	1.48	-44.71	-3.83	-50.67	-10.07	52.99
FCF Conversion (FCF/Net Income)	0.76x	0.60x	0.28x	-0.00x	-1.47x	0.20x	1.35x
Interest Paid	0	97.79K	137.16K	180.74K	194.67K	250.78K	247.62K
Taxes Paid	0	3.9M	4.36M	5.04M	5.7M	3.58M	3.66M

Key Ratios

Metric	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	34.81%	29.64%	26.38%	21.87%	5.09%	8.14%	7.09%
Return on Invested Capital (ROIC)	45.38%	37.33%	27.72%	21.34%	7.28%	8.6%	7.45%
Gross Margin	42.12%	40.45%	41.72%	38.26%	36.86%	34.08%	34.36%
Net Margin	20.44%	19.38%	21.38%	20.14%	6.04%	11.97%	11.19%
Debt / Equity	0.05x	0.04x	0.04x	0.05x	0.05x	0.05x	0.05x
Interest Coverage	-	198.26x	171.09x	145.29x	55.49x	58.52x	9.50x
FCF Conversion	0.76x	0.60x	0.28x	-0.00x	-1.47x	0.20x	1.35x
Revenue Growth	-	5.18%	11.85%	16.82%	-0.66%	-6.05%	-0.19%

Frequently Asked Questions

Valuation & Price

Meihua International Medical Technologies Co., Ltd. (MHUA) has a price-to-earnings (P/E) ratio of 0.1x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Meihua International Medical Technologies Co., Ltd. (MHUA) reported $183.8M in revenue for fiscal year 2024. This represents a 143% increase from $75.7M in 2018.

Meihua International Medical Technologies Co., Ltd. (MHUA) saw revenue decline by 0.2% over the past year.

Yes, Meihua International Medical Technologies Co., Ltd. (MHUA) is profitable, generating $18.6M in net income for fiscal year 2024 (11.2% net margin).

Dividend & Returns

Meihua International Medical Technologies Co., Ltd. (MHUA) has a return on equity (ROE) of 7.1%. This is below average, suggesting room for improvement.

Meihua International Medical Technologies Co., Ltd. (MHUA) generated $12.1M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

Meihua International Medical Technologies Co., Ltd. (MHUA) 10-Year Financial Performance & Capital Metrics

MHUA • • Industrial / General

HealthcareMedical InstrumentsMedical Consumables & DisposablesMedical Packaging & Containers

Revenue $97M -0.2%
EBITDA $15M -1.7%
Net Income $11M -6.7%
EPS (Diluted) 40.00 -18.4%
Gross Margin 34.36% +0.8%
EBITDA Margin 15.36% -1.5%
Operating Margin 14.77% -2.3%
Net Margin 11.19% -6.5%
ROE 7.09% -12.9%
ROIC 7.45% -13.4%
Debt/Equity 0.05 +0.1%
Interest Coverage 9.50 -83.8%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓High quality earnings: Operating CF exceeds net income
✓Healthy 5Y average net margin of 14.1%
✓Trading at only 0.0x book value

✗Weaknesses

✗Weak momentum: RS Rating 0 (bottom 0%)
✗Shares diluted 14.3% in last year
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y4.01%

3Y-2.34%

TTM-11.3%

Profit (Net Income) CAGR

10Y-

5Y-6.81%

3Y-19.71%

TTM-26.27%

EPS CAGR

10Y-

5Y-8.97%

3Y-23.4%

TTM-44.54%

ROCE

10Y Avg24.07%

5Y Avg17.63%

3Y Avg9.45%

Latest9.36%

Peer Comparison

Medical Packaging & Containers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
STVNStevanato Group S.p.A.	1.04B	21.00	48.84	1.72%	12.01%	9.78%		0.31
WSTWest Pharmaceutical Services, Inc.	20.1B	279.41	41.77	-1.98%	16.3%	16.11%	1.38%	0.11
ATRAptarGroup, Inc.	8.21B	125.11	22.62	2.74%	11.45%	14.91%	4.25%	0.43
MHUAMeihua International Medical Technologies Co., Ltd.	181.69M	3.25	0.08	-0.19%	10.09%	11.25%	7.98%	0.05

Profit & Loss

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	75.71M	79.63M	89.06M	104.04M	103.35M	97.1M	96.91M
Revenue Growth %	-	0.05%	0.12%	0.17%	-0.01%	-0.06%	-0%
Cost of Goods Sold+	43.82M	47.42M	51.9M	64.23M	65.25M	64M	63.61M
COGS % of Revenue	0.58%	0.6%	0.58%	0.62%	0.63%	0.66%	0.66%
Gross Profit+	31.89M	32.21M	37.16M	39.81M	38.1M	33.09M	33.3M
Gross Margin %	0.42%	0.4%	0.42%	0.38%	0.37%	0.34%	0.34%
Gross Profit Growth %	-	0.01%	0.15%	0.07%	-0.04%	-0.13%	0.01%
Operating Expenses+	13.1M	12.82M	13.69M	14.5M	22.54M	18.42M	18.99M
OpEx % of Revenue	0.17%	0.16%	0.15%	0.14%	0.22%	0.19%	0.2%
Selling, General & Admin	9.85M	8.68M	10.34M	11.78M	18.68M	12.97M	13.52M
SG&A % of Revenue	0.13%	0.11%	0.12%	0.11%	0.18%	0.13%	0.14%
Research & Development	2.87M	3.21M	2.49M	2.73M	2.96M	2.75M	3.46M
R&D % of Revenue	0.04%	0.04%	0.03%	0.03%	0.03%	0.03%	0.04%
Other Operating Expenses	0	926.2K	864.79K	0	898.66K	2.7M	2.01M
Operating Income+	19.18M	19.39M	23.47M	26.26M	10.8M	14.67M	14.31M
Operating Margin %	0.25%	0.24%	0.26%	0.25%	0.1%	0.15%	0.15%
Operating Income Growth %	-	0.01%	0.21%	0.12%	-0.59%	0.36%	-0.02%
EBITDA+	19.74M	19.9M	23.99M	26.88M	11.37M	15.15M	14.88M
EBITDA Margin %	0.26%	0.25%	0.27%	0.26%	0.11%	0.16%	0.15%
EBITDA Growth %	-	0.01%	0.21%	0.12%	-0.58%	0.33%	-0.02%
D&A (Non-Cash Add-back)	567.77K	509.22K	523.43K	622.47K	563.46K	470.99K	571.03K
EBIT	19.18M	19.35M	23.87M	26.41M	11.09M	15.3M	15.13M
Net Interest Income+	0	-48.95K	-100.58K	-156.89K	-130.94K	622.66K	-492.3K
Interest Income	77.42K	48.84K	36.58K	23.86K	63.73K	873.44K	1.01M
Interest Expense	0	97.79K	137.16K	180.74K	194.67K	250.78K	1.51M
Other Income/Expense	-465.98K	-137.69K	267.35K	-32.91K	89.28K	373.84K	-685.78K
Pretax Income+	18.71M	19.25M	23.73M	26.23M	10.89M	15.05M	13.63M
Pretax Margin %	0.25%	0.24%	0.27%	0.25%	0.11%	0.15%	0.14%
Income Tax+	3.23M	3.82M	4.69M	5.28M	4.71M	3.46M	2.79M
Effective Tax Rate %	0.83%	0.8%	0.8%	0.8%	0.57%	0.77%	0.8%
Net Income+	15.48M	15.43M	19.05M	20.95M	6.24M	11.63M	10.84M
Net Margin %	0.2%	0.19%	0.21%	0.2%	0.06%	0.12%	0.11%
Net Income Growth %	-	-0%	0.23%	0.1%	-0.7%	0.86%	-0.07%
Net Income (Continuing)	15.48M	15.43M	19.05M	20.95M	6.18M	11.59M	10.84M
Discontinued Operations	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	556.14K	505.98K	0
EPS (Diluted)+	77.00	64.00	79.00	89.00	27.00	49.00	40.00
EPS Growth %	-	-0.17%	0.23%	0.13%	-0.7%	0.81%	-0.18%
EPS (Basic)	77.00	64.00	79.00	89.00	27.00	49.00	40.00
Diluted Shares Outstanding	200K	241.4K	241.4K	236K	234.11K	239.4K	273.72K
Basic Shares Outstanding	200K	241.4K	241.4K	236K	234.11K	239.4K	273.72K
Dividend Payout Ratio	-	-	-	-	-	-	-

Balance Sheet

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	49.97M	52.58M	67.57M	97.28M	135.32M	132.24M	143.44M
Cash & Short-Term Investments	14.8M	16.03M	7.19M	8.15M	26.74M	16.93M	15.96M
Cash Only	14.8M	16.03M	7.19M	8.15M	26.74M	16.93M	15.96M
Short-Term Investments	0	0	0	0	0	0	0
Accounts Receivable	32.98M	35.41M	58.56M	86.48M	91.03M	99.48M	115M
Days Sales Outstanding	159	162.33	239.98	303.41	321.51	373.95	433.13
Inventory	1.84M	1.02M	1.33M	1.25M	1.12M	1.62M	1.41M
Days Inventory Outstanding	15.36	7.89	9.33	7.11	6.28	9.22	8.09
Other Current Assets	344.84K	107.94K	496.61K	1.39M	16.43M	14.23M	1.48M
Total Non-Current Assets+	12.45M	20.63M	38.48M	39.58M	28.26M	39.68M	42.8M
Property, Plant & Equipment	3.7M	3.4M	20.13M	7.48M	8.76M	8.84M	7.89M
Fixed Asset Turnover	20.46x	23.41x	4.42x	13.91x	11.80x	10.99x	12.29x
Goodwill	0	0	0	-17.26M	0	0	0
Intangible Assets	600.78K	16.37M	17.43M	17.82M	497.6K	3.92M	443.04K
Long-Term Investments	872.66K	861.85K	919.54K	941.53K	6.67M	6.13M	22.39M
Other Non-Current Assets	7.27M	15.8M	29.89M	30.6M	12.33M	20.42M	11.09M
Total Assets+	62.42M	73.2M	106.05M	136.86M	163.58M	171.92M	186.24M
Asset Turnover	1.21x	1.09x	0.84x	0.76x	0.63x	0.56x	0.52x
Asset Growth %	-	0.17%	0.45%	0.29%	0.2%	0.05%	0.08%
Total Current Liabilities+	17.96M	13.55M	21.31M	29.09M	24.17M	25.07M	27.26M
Accounts Payable	13.73M	9.36M	15.64M	20.98M	16.1M	15.82M	15.48M
Days Payables Outstanding	114.33	72.05	109.98	119.22	90.04	90.23	88.8
Short-Term Debt	2.04M	2.59M	3.22M	5.18M	6.09M	7.32M	7.95M
Deferred Revenue (Current)	0	0	1000K	0	0	0	0
Other Current Liabilities	956.04K	851.17K	-494.98K	0	0	409.89K	1.33M
Current Ratio	2.78x	3.88x	3.17x	3.34x	5.60x	5.27x	5.26x
Quick Ratio	2.68x	3.81x	3.11x	3.30x	5.55x	5.21x	5.21x
Cash Conversion Cycle	60.03	98.17	139.33	191.29	237.74	292.95	352.42
Total Non-Current Liabilities+	0	0	0	0	724.93K	4.59K	0
Long-Term Debt	0	0	0	0	724.93K	0	0
Capital Lease Obligations	0	0	0	0	0	4.59K	0
Deferred Tax Liabilities	0	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	0	0	0	0
Total Liabilities	17.96M	13.55M	21.31M	30.05M	24.9M	25.08M	27.26M
Total Debt+	2.04M	2.59M	3.22M	5.18M	6.81M	7.33M	7.95M
Net Debt	-12.77M	-13.45M	-3.97M	-2.97M	-19.92M	-9.6M	-8.01M
Debt / Equity	0.05x	0.04x	0.04x	0.05x	0.05x	0.05x	0.05x
Debt / EBITDA	0.10x	0.13x	0.13x	0.19x	0.60x	0.48x	0.53x
Net Debt / EBITDA	-0.65x	-0.68x	-0.17x	-0.11x	-1.75x	-0.63x	-0.54x
Interest Coverage	-	198.26x	171.09x	145.29x	55.49x	58.52x	9.50x
Total Equity+	44.46M	59.66M	84.74M	106.81M	138.68M	146.84M	158.98M
Equity Growth %	-	0.34%	0.42%	0.26%	0.3%	0.06%	0.08%
Book Value per Share	222.31	247.13	351.02	452.59	592.36	613.36	580.80
Total Shareholders' Equity	44.46M	59.66M	84.74M	106.81M	138.12M	146.33M	158.98M
Common Stock	10K	10K	10K	10K	11.97K	11.97K	15.95K
Retained Earnings	37.33M	52.76M	56.63M	76.62M	83.33M	94.64M	105.23M
Treasury Stock	0	0	0	0	0	0	-200K
Accumulated OCI	-2.59M	-2.83M	18.38M	20.47M	11.81M	8.72M	4.71M
Minority Interest	0	0	0	0	556.14K	505.98K	0

Cash Flow

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	11.82M	9.31M	5.33M	-54.66K	-9.16M	2.28M	14.64M
Operating CF Margin %	0.16%	0.12%	0.06%	-0%	-0.09%	0.02%	0.15%
Operating CF Growth %	-	-0.21%	-0.43%	-1.01%	-166.63%	1.25%	5.43%
Net Income	15.48M	15.43M	19.05M	19.99M	6.18M	11.59M	10.84M
Depreciation & Amortization	567.77K	509.22K	523.43K	622.47K	563.46K	470.99K	571.03K
Stock-Based Compensation	0	0	0	0	0	0	0
Deferred Taxes	0	0	0	0	0	-370.48K	-642.63K
Other Non-Cash Items	6.71M	-9.53K	2.85K	15.28K	4.51M	2.18M	3.9M
Working Capital Changes	-10.94M	-6.62M	-14.25M	-20.68M	-20.41M	-11.6M	-27.97K
Change in Receivables	-11.09M	-4.71M	-13.64M	-20.07M	-7.12M	-14.02M	-3.21M
Change in Inventory	-170.6K	802.61K	-219.79K	105.12K	35.03K	-528.63K	165.76K
Change in Payables	0	-4.23M	5.34M	4.91M	-3.37M	185.9K	932.49K
Cash from Investing+	-7.57M	-8.9M	-16.09M	-833.82K	-8.62M	-12.46M	-20.42M
Capital Expenditures	-12.3K	-8.95M	-16.12M	-850.23K	-2.7M	-1.18M	-133.55K
CapEx % of Revenue	0%	0.11%	0.18%	0.01%	0.03%	0.01%	0%
Acquisitions	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-
Other Investing	-7.56M	0	0	0	23.15K	-11.63M	-15.9M
Cash from Financing+	-4.2M	923.77K	1.71M	1.86M	37.25M	706.13K	6.21M
Debt Issued (Net)	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-
Other Financing	-4.2M	344.74K	0	0	635.31K	0	0
Net Change in Cash	-	-	-	-	-	-	-
Free Cash Flow+	11.8M	356.12K	-10.79M	-904.89K	-11.86M	-2.41M	14.5M
FCF Margin %	0.16%	0%	-0.12%	-0.01%	-0.11%	-0.02%	0.15%
FCF Growth %	-	-0.97%	-31.31%	0.92%	-12.11%	0.8%	7.02%
FCF per Share	59.02	1.48	-44.71	-3.83	-50.67	-10.07	52.99
FCF Conversion (FCF/Net Income)	0.76x	0.60x	0.28x	-0.00x	-1.47x	0.20x	1.35x
Interest Paid	0	97.79K	137.16K	180.74K	194.67K	250.78K	247.62K
Taxes Paid	0	3.9M	4.36M	5.04M	5.7M	3.58M	3.66M

Key Ratios

Metric	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	34.81%	29.64%	26.38%	21.87%	5.09%	8.14%	7.09%
Return on Invested Capital (ROIC)	45.38%	37.33%	27.72%	21.34%	7.28%	8.6%	7.45%
Gross Margin	42.12%	40.45%	41.72%	38.26%	36.86%	34.08%	34.36%
Net Margin	20.44%	19.38%	21.38%	20.14%	6.04%	11.97%	11.19%
Debt / Equity	0.05x	0.04x	0.04x	0.05x	0.05x	0.05x	0.05x
Interest Coverage	-	198.26x	171.09x	145.29x	55.49x	58.52x	9.50x
FCF Conversion	0.76x	0.60x	0.28x	-0.00x	-1.47x	0.20x	1.35x
Revenue Growth	-	5.18%	11.85%	16.82%	-0.66%	-6.05%	-0.19%

Frequently Asked Questions

Valuation & Price

Meihua International Medical Technologies Co., Ltd. (MHUA) has a price-to-earnings (P/E) ratio of 0.1x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Meihua International Medical Technologies Co., Ltd. (MHUA) reported $183.8M in revenue for fiscal year 2024. This represents a 143% increase from $75.7M in 2018.

Meihua International Medical Technologies Co., Ltd. (MHUA) saw revenue decline by 0.2% over the past year.

Yes, Meihua International Medical Technologies Co., Ltd. (MHUA) is profitable, generating $18.6M in net income for fiscal year 2024 (11.2% net margin).

Dividend & Returns

Meihua International Medical Technologies Co., Ltd. (MHUA) has a return on equity (ROE) of 7.1%. This is below average, suggesting room for improvement.

Meihua International Medical Technologies Co., Ltd. (MHUA) generated $12.1M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.